Annual EBITDA
-$153.79 M
+$137.00 K+0.09%
December 31, 2023
Summary
- As of February 8, 2025, OM annual EBITDA is -$153.79 million, with the most recent change of +$137.00 thousand (+0.09%) on December 31, 2023.
- During the last 3 years, OM annual EBITDA has fallen by -$38.35 million (-33.22%).
- OM annual EBITDA is now -249.15% below its all-time high of -$44.05 million, reached on December 31, 2018.
Performance
OM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$20.30 M
+$6.52 M+24.32%
September 30, 2024
Summary
- As of February 8, 2025, OM quarterly EBITDA is -$20.30 million, with the most recent change of +$6.52 million (+24.32%) on September 30, 2024.
- Over the past year, OM quarterly EBITDA has increased by +$21.12 million (+50.99%).
- OM quarterly EBITDA is now -42.90% below its all-time high of -$14.21 million, reached on September 30, 2019.
Performance
OM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$113.10 M
+$21.12 M+15.73%
September 30, 2024
Summary
- As of February 8, 2025, OM TTM EBITDA is -$113.10 million, with the most recent change of +$21.12 million (+15.73%) on September 30, 2024.
- Over the past year, OM TTM EBITDA has increased by +$45.08 million (+28.50%).
- OM TTM EBITDA is now -696.20% below its all-time high of -$14.21 million, reached on September 30, 2019.
Performance
OM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.1% | +51.0% | +28.5% |
| 3 y3 years | -33.2% | +51.0% | +28.5% |
| 5 y5 years | -249.2% | +51.0% | +28.5% |
OM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.2% | +0.1% | at high | +51.6% | at high | +28.6% |
| 5 y | 5-year | -145.9% | +0.1% | -12.4% | +51.6% | -250.6% | +28.6% |
| alltime | all time | -249.2% | +0.1% | -42.9% | +51.6% | -696.2% | +28.6% |
Outset Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.30 M(-24.3%) | -$113.10 M(-15.7%) |
| Jun 2024 | - | -$26.82 M(-17.1%) | -$134.22 M(-8.5%) |
| Mar 2024 | - | -$32.35 M(-3.8%) | -$146.69 M(-4.6%) |
| Dec 2023 | -$153.79 M(-0.1%) | -$33.63 M(-18.8%) | -$153.79 M(-2.8%) |
| Sep 2023 | - | -$41.41 M(+5.4%) | -$158.18 M(+1.6%) |
| Jun 2023 | - | -$39.30 M(-0.4%) | -$155.64 M(-1.7%) |
| Mar 2023 | - | -$39.45 M(+3.8%) | -$158.29 M(+2.8%) |
| Dec 2022 | -$153.93 M(+23.3%) | -$38.02 M(-2.2%) | -$153.93 M(-0.9%) |
| Sep 2022 | - | -$38.88 M(-7.3%) | -$155.29 M(+7.0%) |
| Jun 2022 | - | -$41.94 M(+19.5%) | -$145.14 M(+10.3%) |
| Mar 2022 | - | -$35.09 M(-10.9%) | -$131.63 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$124.86 M(+8.2%) | -$39.38 M(+37.1%) | -$124.86 M(+8.4%) |
| Sep 2021 | - | -$28.73 M(+1.0%) | -$115.16 M(-9.9%) |
| Jun 2021 | - | -$28.43 M(+0.4%) | -$127.76 M(+2.7%) |
| Mar 2021 | - | -$28.32 M(-4.6%) | -$124.41 M(+7.8%) |
| Dec 2020 | -$115.44 M(+84.6%) | -$29.68 M(-28.2%) | -$115.44 M(+11.2%) |
| Sep 2020 | - | -$41.32 M(+64.7%) | -$103.81 M(+35.4%) |
| Jun 2020 | - | -$25.09 M(+29.7%) | -$76.69 M(+48.6%) |
| Mar 2020 | - | -$19.34 M(+7.1%) | -$51.60 M(+60.0%) |
| Dec 2019 | -$62.54 M(+42.0%) | -$18.05 M(+27.1%) | -$32.26 M(+127.1%) |
| Sep 2019 | - | -$14.21 M | -$14.21 M |
| Dec 2018 | -$44.05 M | - | - |
FAQ
- What is Outset Medical annual EBITDA?
- What is the all time high annual EBITDA for Outset Medical?
- What is Outset Medical annual EBITDA year-on-year change?
- What is Outset Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Outset Medical?
- What is Outset Medical quarterly EBITDA year-on-year change?
- What is Outset Medical TTM EBITDA?
- What is the all time high TTM EBITDA for Outset Medical?
- What is Outset Medical TTM EBITDA year-on-year change?
What is Outset Medical annual EBITDA?
The current annual EBITDA of OM is -$153.79 M
What is the all time high annual EBITDA for Outset Medical?
Outset Medical all-time high annual EBITDA is -$44.05 M
What is Outset Medical annual EBITDA year-on-year change?
Over the past year, OM annual EBITDA has changed by +$137.00 K (+0.09%)
What is Outset Medical quarterly EBITDA?
The current quarterly EBITDA of OM is -$20.30 M
What is the all time high quarterly EBITDA for Outset Medical?
Outset Medical all-time high quarterly EBITDA is -$14.21 M
What is Outset Medical quarterly EBITDA year-on-year change?
Over the past year, OM quarterly EBITDA has changed by +$21.12 M (+50.99%)
What is Outset Medical TTM EBITDA?
The current TTM EBITDA of OM is -$113.10 M
What is the all time high TTM EBITDA for Outset Medical?
Outset Medical all-time high TTM EBITDA is -$14.21 M
What is Outset Medical TTM EBITDA year-on-year change?
Over the past year, OM TTM EBITDA has changed by +$45.08 M (+28.50%)